ZINPLAVA conc perf 1000 mg/40ml flac 40 ml

7680663440011 CH-66344 J06BB21 08.01.
ZINPLAVA conc perf 1000 mg/40ml flac 40 ml
ZINPLAVA conc perf 1000 mg/40ml flac 40 ml
ZINPLAVA conc perf 1000 mg/40ml flac 40 ml
1 / 3
google

Details

Product number
6634401
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
bezlotoxumabum 25 mg, natrii chloridum, natrii citras dihydricus, acidum citricum monohydricum, polysorbatum 80, acidum penteticum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Zinplava, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
21/08/2025
Professional SmPC
Français
21/08/2025
Professional SmPC
Italien
21/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.57 MG Substance HBESI

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
66344
Drug name
Zinplava, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
J06BC03
Authorization status
Z
Dispensation category
A
First authorization
20/11/2017
Authorization expiration date
30/06/2026
IT number
08.01.
Domain
Human medicine
Field of application
Prävention eines Rezidivs einer Clostridium difficile Infektion (CDI)

Packaging details

Description (FR)
ZINPLAVA conc perf 25 mg 1 pce
Description (DE)
ZINPLAVA Konz Inf 25 mg 1 Stk
Market launch
20/11/2017
Narcotic (BTM)
No